Get started
Author

Hiroko Matsuura

Observed names: H. Matsuura, HIROKO MATSUURA, Hiroko MATSUURA, Matsuura, H.
ORCID: 0000-0002-1825-6245
Observed ORCID: 0000-0002-1825-6245
OpenAlex ID: A5028119987
Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients
2019 · Tadashi Aoyama, Masashi Takano, et al. · Oncology · 65
Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature
2021 · Taira Hada, Morikazu Miyamoto, et al. · Journal of Ovarian Research · 28
PDF
Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis
2021 · Soichiro Kakimoto, Morikazu Miyamoto, et al. · Diagnostic Pathology · 23
PDF
Criteria for placenta accreta spectrum in the International Federation of Gynaecology and Obstetrics classification, and topographic invasion area are associated with massive hemorrhage in patients with placenta previa
2021 · Hiroki Ishibashi, Morikazu Miyamoto, et al. · Acta Obstetricia Et Gynecologica Scandinavica · 23
The use of magnetic resonance imaging to predict placenta previa with placenta accreta spectrum
2020 · Hiroki Ishibashi, Morikazu Miyamoto, et al. · Acta Obstetricia Et Gynecologica Scandinavica · 19
Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma
2019 · Kazuki Takasaki, Morikazu Miyamoto, et al. · International Journal of Clinical Oncology · 18
Psoas muscle index at the fifth lumbar vertebra as a predictor of survival in epithelial ovarian cancers
2021 · Tomoyuki Yoshikawa, Morikazu Miyamoto, et al. · Molecular and Clinical Oncology · 16
PDF
Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors
2020 · TAIRA HADA, MORIKAZU MIYAMOTO, et al. · In Vivo · 15
PDF
Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma
2020 · Soichiro Kakimoto, Morikazu Miyamoto, et al. · Pathology & Oncology Research · 14
Diagnostic efficacy of ascites cell block for ovarian clear cell carcinoma
2021 · Hideki Iwahashi, Morikazu Miyamoto, et al. · Diagnostic Cytopathology · 12
Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: a retrospective analysis
2022 · Jin Suminokura, Morikazu Miyamoto, et al. · BMC Cancer · 11
PDF
Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis
2018 · Kazuki Takasaki, Morikazu Miyamoto, et al. · Cancer Chemotherapy and Pharmacology · 11
Role of endometriosis as a prognostic factor for post‑progression survival in ovarian clear cell carcinoma
2017 · Hiroki Ishibashi, Masashi Takano, et al. · Molecular and Clinical Oncology · 10
PDF
Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
2022 · Taira Hada, Morikazu Miyamoto, et al. · Diagnostic Pathology · 9
PDF
Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis
2021 · Taira Hada, Morikazu Miyamoto, et al. · Medicine · 9
Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine
2020 · Hiroaki Soyama, Morikazu Miyamoto, et al. · Cancer Chemotherapy and Pharmacology · 9
Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin
2017 · Hiroaki Soyama, Morikazu Miyamoto, et al. · Medical Oncology · 8
The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomas
2022 · Hiroko Matsuura, Morikazu Miyamoto, et al. · Archives of Gynecology and Obstetrics · 7
Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases
2021 · Taira Hada, Morikazu Miyamoto, et al. · Molecular and Clinical Oncology · 6
Applicability of ultrasonography for detection of marginal sinus placenta previa
2021 · Hiroki Ishibashi, Morikazu Miyamoto, et al. · Medicine · 6
Placenta previa may acquire invasive nature by factors associated with epithelial‐mesenchymal transition and matrix metalloproteinases
2020 · Hiroaki Soyama, Morikazu Miyamoto, et al. · Journal of obstetrics and gynaecology research · 6
Is Modified Radical Hysterectomy Needed for Patients with Clinical Stage I/II Endometrial Cancers? A Historical Control Study
2016 · Morikazu Miyamoto, Masashi Takano, et al. · Oncology · 6
Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma
2022 · Hideki Iwahashi, Morikazu Miyamoto, et al. · Cancer Medicine · 5
PDF
A New Model to Improve the Prediction of Prognosis of Endometrial Carcinoma by Combining Traditional Classification With the Presence of Tumor-infiltrating Lymphocytes
2021 · MORIKAZU MIYAMOTO, TAIRA HADA, et al. · Anticancer Research · 5
PDF
A Case of Parasitic Leiomyoma in the Sigmoid Mesentery Following Total Laparoscopic Hysterectomy
2024 · Taro Miyake, Yuichiro Tateno, et al. · Cureus · 4
PDF
Works count: 48
Citation count: 352
H-index: 11
I10-index: 13
Year
Topic
Type